Hyaluronic Acid for Joint Pain: What the Evidence Shows for Injections and Oral Supplements

Hyaluronic acid is a natural component of synovial fluid — the thick, viscous fluid filling the joint cavity that reduces friction between cartilage surfaces and acts as a shock absorber during movement. In osteoarthritis, both the concentration and the molecular weight of hyaluronic acid in synovial fluid decrease, which theoretically weakens its protective and lubricating properties — this observation is exactly what led to the idea of replenishing it directly in the joint through so-called viscosupplementation.

It's worth distinguishing right away between two very different interventions often treated as the same thing in casual conversation: intra-articular hyaluronic acid injections, administered by a doctor directly into the joint cavity, and oral hyaluronic acid supplements, taken as tablets or capsules. The mechanism of action, the route the substance takes to reach the joint, and — as it turns out — the quality of the evidence are fundamentally different in each case.

The most influential summary of evidence in this area is a network meta-analysis published in Annals of Internal Medicine, comparing nearly every available pharmacological treatment for knee osteoarthritis — from acetaminophen, through nonsteroidal anti-inflammatory drugs, to intra-articular hyaluronic acid and corticosteroid injections.

Despite its high score in the network meta-analysis, the American Academy of Orthopaedic Surgeons (AAOS), in its 2013 clinical practice guideline, issued a strong recommendation against the routine use of hyaluronic acid injections for knee osteoarthritis, citing improvement that failed to clear the threshold for clinically important difference in a portion of high-quality trials. In the updated 2021 guideline, that recommendation was softened to moderate strength, but the direction stayed the same — injections are not recommended for routine use.

Oral hyaluronic acid supplements are marketed as a more convenient, non-invasive alternative to injections. Biologically, though, this is a completely different intervention: hyaluronic acid taken orally has to pass through the digestive tract, be absorbed, and somehow reach the joint — a far less direct process than injecting the substance straight into the joint cavity, and for that reason harder to justify mechanistically from the outset.

A second widespread myth is the belief that a high ranking for injections in an effectiveness table means an unambiguous, indisputable recommendation to use it in every patient with joint pain. In reality, the meta-analysis's own authors and some orthopedic societies emphasize that the effect may be substantially driven by the act of injection itself rather than a unique action of hyaluronic acid — hence the divergent, sometimes conflicting clinical guidelines.

Hyaluronic acid for joint pain is a good example of how important it is to distinguish the route of administration when evaluating scientific evidence. Intra-articular injections have a solid, though methodologically disputed, evidence base and can be a reasonable option for select patients after simpler methods have failed — provided there's awareness that part of the effect may come from the procedure itself, not just the substance. Oral supplements, despite their popularity and convenience, currently lack solid evidence of an advantage over placebo and shouldn't be treated as an equivalent alternative.